SWITCH-BLOCKER

Owners

Goods & Services

Health assessment services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; and consulting services in the fields of diagnostic medical testing and treatment of diseases

Medical, scientific and clinical research in the fields of diagnostics, genomics, next generation sequencing (NGS) and therapeutics, molecular diagnostics for the detection of DNA and RNA targets of interest, Sanger sequencing, NGS, capillary electrophoresis, mass-spectral analysis, and microarray analysis

Medical diagnostic apparatus and instruments for testing DNA and RNA and for diagnostic testing for the interrogation of DNA and RNA nucleic acids for any disease or condition where it is desired to detect specific nucleic acids or derivative thereof, namely, cancer, an infectious disease, inherited genetic disease, somatic aberration, and rejection of transplanted organs

Medical diagnostic reagents and assays for testing of bodily fluids for use in detection of any disease or condition where it is desired to detect specific nucleic acids or derivatives thereof, namely, cancer, infectious disease, inherited genetic disease, somatic aberration, and rejection of transplanted organs; drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of gene events, namely, mutations, single nucleotide polymorphisms (SNP's) and other disease biomarkers, translocations, deletions, gene copy number changes, RNA expression levels, and biomarkers specific to disease conditions; drug testing kits comprised of medical diagnostic reagents and assays, test strips, test patches, and test media for testing of bodily fluids for use in detection of any disease or condition where it is desired to detect specific nucleic acids or derivatives thereof, namely, cancer, infectious disease, inherited genetic disease, somatic aberration, and rejection of transplanted organs